JPS6033433B2 - ハロゲン置換ベンゾピラン−４−カルボン酸およびその誘導体 - Google Patents

ハロゲン置換ベンゾピラン−４−カルボン酸およびその誘導体

Info

Publication number
JPS6033433B2
JPS6033433B2 JP54144280A JP14428079A JPS6033433B2 JP S6033433 B2 JPS6033433 B2 JP S6033433B2 JP 54144280 A JP54144280 A JP 54144280A JP 14428079 A JP14428079 A JP 14428079A JP S6033433 B2 JPS6033433 B2 JP S6033433B2
Authority
JP
Japan
Prior art keywords
compound according
dihydro
chloro
acid
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54144280A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5585582A (en
Inventor
ジヨン・エル・ベルテイア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Original Assignee
PFIZER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER filed Critical PFIZER
Publication of JPS5585582A publication Critical patent/JPS5585582A/ja
Publication of JPS6033433B2 publication Critical patent/JPS6033433B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
JP54144280A 1978-11-08 1979-11-07 ハロゲン置換ベンゾピラン−４−カルボン酸およびその誘導体 Expired JPS6033433B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/959,023 US4210663A (en) 1978-11-08 1978-11-08 Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids
US959023 1992-10-09

Publications (2)

Publication Number Publication Date
JPS5585582A JPS5585582A (en) 1980-06-27
JPS6033433B2 true JPS6033433B2 (ja) 1985-08-02

Family

ID=25501572

Family Applications (2)

Application Number Title Priority Date Filing Date
JP54144280A Expired JPS6033433B2 (ja) 1978-11-08 1979-11-07 ハロゲン置換ベンゾピラン−４−カルボン酸およびその誘導体
JP17706780A Granted JPS56103176A (en) 1978-11-08 1980-12-15 Halogen substituted benzothiopyranee44carboxylic acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP17706780A Granted JPS56103176A (en) 1978-11-08 1980-12-15 Halogen substituted benzothiopyranee44carboxylic acids

Country Status (16)

Country Link
US (1) US4210663A (2)
EP (1) EP0011426B1 (2)
JP (2) JPS6033433B2 (2)
KR (1) KR830001821B1 (2)
AR (1) AR223195A1 (2)
AT (1) AT366680B (2)
AU (1) AU513399B2 (2)
CA (1) CA1132584A (2)
DE (1) DE2965755D1 (2)
DK (1) DK153947C (2)
ES (1) ES485798A1 (2)
FI (1) FI71139C (2)
IE (1) IE49109B1 (2)
IL (1) IL58656A (2)
PT (1) PT70420A (2)
YU (1) YU41675B (2)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014439A1 (fr) * 1991-02-18 1992-09-03 Chugai Seiyaku Kabushiki Kaisha Agent stimulant la croissance des cheveux
WO1999043315A1 (en) * 1998-02-25 1999-09-02 Shionogi & Co., Ltd. Therapeutic agent for complication of diabetes

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305955A (en) * 1980-10-21 1981-12-15 Pfizer Inc. Carboxylic acid therapeutic agents
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
US4537920A (en) * 1983-08-18 1985-08-27 Ethyl Corporation 4H-1-benzopyrans and lubricant compositions containing same
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
WO1987004344A1 (en) * 1986-01-17 1987-07-30 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
ATE161254T1 (de) * 1990-07-27 1998-01-15 Chugai Pharmaceutical Co Ltd Benzopyranderivat
US5407897A (en) * 1993-03-03 1995-04-18 American Cyanamid Company Method for safening herbicides in crops using substituted benzopyran and tetrahydronaphthalene compounds
US7288279B2 (en) * 2001-12-21 2007-10-30 Michael Foods Of Delaware, Inc. Formulated fried egg product
JP4742215B2 (ja) * 2003-06-23 2011-08-10 Ｊｎｃ株式会社 クロマン化合物、この化合物を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子
JP5956920B2 (ja) 2012-12-14 2016-07-27 株式会社コガネイ 液体供給装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014439A1 (fr) * 1991-02-18 1992-09-03 Chugai Seiyaku Kabushiki Kaisha Agent stimulant la croissance des cheveux
WO1999043315A1 (en) * 1998-02-25 1999-09-02 Shionogi & Co., Ltd. Therapeutic agent for complication of diabetes

Also Published As

Publication number Publication date
JPS6113716B2 (2) 1986-04-15
US4210663A (en) 1980-07-01
ATA719279A (de) 1981-09-15
AR223195A1 (es) 1981-07-31
IE792136L (en) 1980-05-08
EP0011426B1 (en) 1983-06-22
CA1132584A (en) 1982-09-28
DK153947C (da) 1989-02-20
KR830001821B1 (ko) 1983-09-12
FI71139C (fi) 1986-11-24
DK471079A (da) 1980-05-09
AU5258279A (en) 1980-05-15
EP0011426A1 (en) 1980-05-28
AU513399B2 (en) 1980-11-27
IL58656A0 (en) 1980-02-29
DE2965755D1 (en) 1983-07-28
ES485798A1 (es) 1980-10-01
YU41675B (en) 1987-12-31
JPS56103176A (en) 1981-08-18
FI793487A7 (fi) 1980-05-09
KR830001273A (ko) 1983-04-30
DK153947B (da) 1988-09-26
PT70420A (de) 1979-12-01
JPS5585582A (en) 1980-06-27
AT366680B (de) 1982-04-26
IL58656A (en) 1983-06-15
FI71139B (fi) 1986-08-14
IE49109B1 (en) 1985-08-07
YU269779A (en) 1983-02-28

Similar Documents

Publication Publication Date Title
US4130714A (en) Hydantoin therapeutic agents
US4200642A (en) Spiro-oxazolidindiones
US5847128A (en) Water soluble derivatives of cannabinoids
JPS6033433B2 (ja) ハロゲン置換ベンゾピラン−４−カルボン酸およびその誘導体
JPH0948771A (ja) Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
JPS607997B2 (ja) ヒダントイン誘導体治療剤
JPS6210508B2 (2)
HU206714B (en) Process for producing pyridazine derivatives
US4950818A (en) Method for treating ulcer
US4209527A (en) Benzimidazolone derivatives
JPS62252774A (ja) フタラジン誘導体およびその製造法
JPS58198467A (ja) 新規プロスタグランデイン誘導体類
JPS5840959B2 (ja) アルド−ス還元酵素阻害剤スピロ−キノリルヒダントイン誘導体
GB2193210A (en) Glycine derivatives
JP4010377B2 (ja) Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
US4177282A (en) Hydantoin therapeutic agents
US4267342A (en) Spiro-oxazolidindiones
US4098799A (en) 3-formylchromones
CA2026274A1 (en) Imidazoles
US5084464A (en) Conjugated γ-hydroxybutenolide compounds and antiulcer agents containing the same as an effective ingredient
KR830000329B1 (ko) 스피로-옥사졸리딘디온의 제조방법
EP1314729A1 (en) Biologically active 4H-benzo(1,4)oxazin-3-ones
US4305877A (en) Novel spiro-oxazolidindiones
JPS582955B2 (ja) スピロ−キノロンヒダントイン類
US3879426A (en) Hydroxymethylene-substituted chromone-3-carboxaldehydes and process for their preparation